immune checkpoint inhibitors

You have access
Possible Pseudo-progression of Non-small Cell Lung Carcinoma in a Patient With Clinical Hyper-progression Associated With Trousseau Syndrome Who Was Treated With Pembrolizumab: A Case Report
YOSUKE SHIONOYA, YOSHIHIKO HIROHASHI, HARUKA TAKAHASHI, MIDORI HASHIMOTO, KAORU NISHIYAMA, YASUNARI TAKAKUWA, MUNEHIDE NAKATSUGAWA, TERUFUMI KUBO, TAKAYUKI KANASEKI, TOMOHIDE TSUKAHARA and TOSHIHIKO TORIGOE

Anticancer Research July 2021, 41 (7) 3699-3706; DOI: https://doi.org/10.21873/anticanres.15161
You have access
T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES

Anticancer Research March 2021, 41 (3) 1123-1141; DOI: https://doi.org/10.21873/anticanres.14870
You have access
Site-specific Response to Nivolumab in Renal Cell Carcinoma
TAKAHITO NEGISHI, NOBUKI FURUBAYASHI, TOHRU NAKAGAWA, NAOTAKA NISHIYAMA, HIROSHI KITAMURA, YOSHIFUMI HORI, KENTAROU KUROIWA, YUHYON SON, NARIHITO SEKI, TOSHIHISA TOMODA, EIJIRO OKAJIMA and MOTONOBU NAKAMURA

Anticancer Research March 2021, 41 (3) 1539-1545; DOI: https://doi.org/10.21873/anticanres.14913
You have access
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma
TAIGO KATO, EISUKE TOMIYAMA, YOKO KOH, MAKOTO MATSUSHITA, YUJIRO HAYASHI, KOSUKE NAKANO, YU ISHIZUYA, CONG WANG, KOJI HATANO, ATSUNARI KAWASHIMA, TAKESHI UJIKE, KEISUKE KAWASAKI, EIICHI MORII, KUNIHITO GOTOH, HIDETOSHI EGUCHI, KAZUMA KIYOTANI, KAZUTOSHI FUJITA, NORIO NONOMURA and MOTOHIDE UEMURA

Anticancer Research September 2020, 40 (9) 4875-4883; DOI: https://doi.org/10.21873/anticanres.14490
You have access
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
TOMONORI HIRASHIMA, TOMOHIRO KANAI, HIDEKAZU SUZUKI, HIROKO YOSHIDA, AKANE MATSUSHITA, HIROMI KAWASUMI, YUMIKO SAMEJIMA, YOSHIMI NODA, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, SHOJI HASHIMOTO, KUNIMITSU KAWAHARA, YOSHITAKA TAMURA, NORIO OKAMOTO and TOSHIO TANAKA

Anticancer Research November 2019, 39 (11) 6231-6240; DOI: https://doi.org/10.21873/anticanres.13832
You have access
Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies
KOHEI FUJITA, NAOHIRO UCHIDA, YUKI YAMAMOTO, OSAMU KANAI, MISATO OKAMURA, KOICHI NAKATANI, SATORU SAWAI and TADASHI MIO

Anticancer Research July 2019, 39 (7) 3917-3921; DOI: https://doi.org/10.21873/anticanres.13543
You have access
Melanoma of the Vagina: Case Report and Systematic Review of the Literature
VIOLETTA RAPI, ASKIN DOGAN, BEATE SCHULTHEIS, FRANZISKA HARTMANN, GÜNTHER A. REZNICZEK and CLEMENS B. TEMPFER

Anticancer Research December 2017, 37 (12) 6911-6920;
You have access
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA

Anticancer Research January 2017, 37 (1) 21-33;

Main menu

User menu

Search

immune checkpoint inhibitors

Pages